Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,985,491 papers from all fields of science
Search
Sign In
Create Free Account
TEMPI Syndrome
A rare syndrome characterized by telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The First Case of TEMPI Syndrome in Japan
Tatsunori Shizuku
,
K. Matsui
,
S. Yagi
,
S. Iwabuchi
Internal medicine
2020
Corpus ID: 215793732
TEMPI syndrome, a disease entity comprising telangiectasia, erythrocytosis with high erythropoietin, monoclonal gammopathy…
Expand
2019
2019
Le TEMPI syndrome, cause exceptionnelle de polyglobulie associée à une gammapathie monoclonale
J. Maquet
,
K. Paricaud
,
+10 authors
L. Sailler
2019
Corpus ID: 212763848
2015
2015
Difficulties in hematopoietic progenitor cell collection from a patient with TEMPI syndrome and severe iatrogenic iron deficiency
R. Belizaire
,
D. Sykes
,
Yi-Bin Chen
,
T. Spitzer
,
R. Makar
Transfusion
2015
Corpus ID: 40843149
Collection of hematopoietic progenitor cells by apheresis (HPC‐A) requires separation of cells by density. Previous studies…
Expand
2013
2013
Too Much Blood: A Case of the Newly Described TEMPI Syndrome
A. Ryden
,
K. Wei
,
R. Rodríguez
,
T. Mahrer
2013
Corpus ID: 71596179
2011
2011
The TEMPI Syndrome: Telangiectasias, Elevated Erythropoietin and Erythrocytosis, Monoclonal Gammopathy, Perinephric Fluid Collections, and Intrapulmonary Shunting
D. Sykes
,
W. Schroyens
,
+11 authors
E. Attar
2011
Corpus ID: 78675467
Abstract 1037 We report a rare and novel syndrome which we have termed TEMPI: telangiectasias, elevated erythropoietin and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE